JAMA Oncology Author Interviews - TopPodcast.com

View Top 200 Chart

Back to Rankings Page

JAMA Oncology Author Interviews — Health & Fitness
JAMA Oncology Author Interviews

Interviews with authors of articles from JAMA Oncology. JAMA Oncology is the definitive journal for scientists, clinicians, and trainees in the field of oncology worldwide. Our original, innovative, and timely scientific and educational content provides a deeper understanding of cancer pathogenesis and recent treatment advances for our readers. JAMA Oncology aims to effectively convey the findings of important clinical research, major scientific breakthroughs, actionable discoveries, and state-of-the-art treatment pathways to the oncology community. Our goal is that successful communication of new knowledge will ultimately translate to clinical benefit for people living with and surviving cancer.

Latest Episodes:

Outcomes for Biomarker-Based Treatment Strategies in Refractory Malignant Neoplasms Jun 06, 2016

Show notes

Interview with Razelle Kurzrock, MD, author of Association of Biomarker-Based Treatment Strategies With Response Rates and Progression-Free Survival in Refractory Malignant Neoplasms: A Meta-analysis

Physiologic Frailty in Hematopoietic Cell Transplantation Patients Jun 02, 2016

Show notes

Interview with Smita Bhatia, MD, MPH, author of Physiologic Frailty in Nonelderly Hematopoietic Cell Transplantation Patients: Results From the Bone Marrow Transplant Survivor Study

Lifestyle Associations With US Cancer Incidence and Mortality May 19, 2016

Show notes

Interview with Mingyang Song, MD, ScD, author of Preventable Incidence and Mortality of Carcinoma Associated With Lifestyle Factors Among Whites in the United States

Neratinib vs Trastuzumab for Untreated Metastatic ERBB2-Positive Breast Cancer Apr 14, 2016

Show notes

Interview with Ahmad Awada, MD, PhD, author of Neratinib Plus Paclitaxel vs Trastuzumab Plus Paclitaxel in Previously Untreated Metastatic ERBB2-Positive Breast Cancer: The NEfERT-T Randomized Clinical Trial, and Mark D. Pegram, MD, author of Neratinib in ERBB2-Positive Brain Metastases

Prostate-Specific Antigen Screening and Selective Treatment Mar 24, 2016

Show notes

Interview with Ruth Etzioni, PhD, author of Economic Analysis of Prostate-Specific Antigen Screening and Selective Treatment Strategies, and Andrew J. Vickers, PhD, author of Does Prostate-Specific Antigen Screening Do More Good Than Harm? Depends on How You Do It

Effect of Long-term Use of Aspirin on the Risk for Cancer Mar 03, 2016

Show notes

Interview with Andrew T. Chan, MD, MPH, author of Population-wide Impact of Long-term Use of Aspirin and the Risk for Cancer

BRCA1 and BRCA2 Mutation Testing in Young Women With Breast Cancer Feb 11, 2016

Show notes

Interview with Ann H. Partridge, MD, MPH, author of BRCA1 and BRCA2 Mutation Testing in Young Women With Breast Cancer

Molecular Profiling in Pediatric Tumors Jan 28, 2016

Show notes

Interview with Katherine A. Janeway, MD, MSc, author of Multicenter Feasibility Study of Tumor Molecular Profiling to Inform Therapeutic Decisions in Advanced Pediatric Solid Tumors: The Individualized Cancer Therapy (iCat) Study, and D. Williams Parsons, MD, PhD, author of Diagnostic Yield of Clinical Tumor and Germline Whole-Exome Sequencing for Children With Solid Tumors

Delayed Initiation of Chemotherapy and Breast Cancer Dec 10, 2015

Show notes

Interview with Mariana Chavez-MacGregor, MD, MSc, author of Delayed Initiation of Adjuvant Chemotherapy Among Patients With Breast Cancer, and Richard J. Bleicher, MD, author of Time to Surgery and Breast Cancer Survival in the United States

Erlotinib and the Risk of Oral Cancer Nov 05, 2015

Show notes

Interview with William N. William Jr, MD, and Scott M. Lippman, MD, author of Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial

Related Podcasts